Table 1.
The relationship of FEN1 expression in HCC with clinicopathological characteristics.
| Characteristics | FEN1 | |||
|---|---|---|---|---|
| Low | High | P value | ||
| Sex | Female | 136 (51.9%) | 126 (48.1%) | 0.715 |
| Male | 37 (49.3%) | 38 (50.7%) | ||
|
| ||||
| Age | <50 | 65 (52%) | 60 (48%) | 0.851 |
| ≥50 | 108 (50.9%) | 104 (49.1%) | ||
|
| ||||
| Liver cirrhosis | Present | 160 (51.3%) | 152 (48.7%) | 0.945 |
| Absent | 13 (52%) | 12 (48%) | ||
|
| ||||
| AFP | <20 | 82 (50%) | 82 (50%) | 0.633 |
| ≥20 | 91 (52.6%) | 82 (47.4%) | ||
|
| ||||
| Tumor multiplicity | Multiple | 43 (54.4%) | 36 (45.6%) | 0.529 |
| Single | 130 (50.4%) | 128 (49.6%) | ||
|
| ||||
| Pathologic TNM stage | I/II | 168 (63.4%) | 97 (36.6%) | <0.001 |
| III/IV | 17 (23.61%) | 55 (76.39%) | ||